Abstract:Background: Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, psychiatric symptoms and behavioral disorders, resulting in disability, and loss of self-sufficiency. Objective: To establish an AD-like mice model, investigate the behavioral performance, and explore the potential mechanism. Methods: Streptozotocin (STZ, 3 mg/kg) was microinjected bilaterally into the dorsal hippocampus of C57BL/6 mice, and the behavioral performance was observed. The serum concentrations of insulin and nesfatin-1 were measured by ELISA, and the activation of hippocampal microglia and astrocytes was assessed by immunohistochemistry. The protein expression of several molecular associated with the regulation of synaptic plasticity in the hippocampus and the pre-frontal cortex (PFC) was detected via western blotting. Results: The STZ-microinjected model mice showed a slower bodyweight gain and higher serum concentration of insulin and nesfatin-1. Although there was no significant difference between groups with regard to the ability of balance and motor coordination, the model mice presented a decline of spontaneous movement and exploratory behavior, together with an impairment of learning and memory ability. Increased activated microglia was aggregated in the hippocampal dentate gyrus of model mice, together with an increase abundance of Aβ 1−42 and Tau in the hippocampus and PFC. Moreover, the protein expression of NMDAR2A, NMDAR2B, SynGAP, PSD95, BDNF, and p-β-catenin/β-catenin were remarkably decreased in the hippocampus and the PFC of model mice, and the expression of p-GSK-3β (ser9)/GSK-3β were reduced in the hippocampus. Conclusion: A bilateral hippocampal microinjection of STZ could induce not only AD-like behavioral performance in mice, but also adaptive changes of synaptic plasticity against neuroinflammatory and endocrinal injuries. The underlying mechanisms might be associated with the imbalanced expression of the key proteins of Wnt signaling pathway in the hippocampus and the PFC.

Effect of Pioglitazone on the spatial memory and hippocampal structure in model of SAD rates

Expression Changes of Growth-Associated Protein-43 (Gap-43) and Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and in Hippocampus of Streptozotocin-Induced Diabetic Cognitive Impairment Rats

The effect of intracerebroventricular injection of streptozotocin on rat spatial learning/memory,the number of hippocampal CA1 neurons and the expression of hippocampal synaptophysin

Shen Qi Wan Ameliorates Learning and Memory Impairment Induced by STZ in AD Rats Through PI3K/AKT Pathway

[The Investigation of Syn and NPY Expression in Brain Tissues of Diabetic Model Rat Induced by Streptozotocin].

Change of hippocampal synaptophysin in rats after intracerebroventricular streptozotocin treated rates

Pioglitazone Ameliorates Memory Deficits In Streptozotocin-Induced Diabetic Mice By Reducing Brain Beta-Amyloid Through Ppar Gamma Activation

Effect and Mechanism of Auricularia Auriculajudae Polysaccharide in Hippocampus of Streptozotocin‐induced Diabetic Cognitive Impairment Rats

Effects of Analog P165 of Amyloid Precursor Protein 5-Mer Peptide on Learning, Memory and Brain Insulin Receptors in the Rat Model of Cognitive Decline.

Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model

The Effect of Cilostazol on Expression of Thrombospondin-1 in Diabetic Retinopathy.

Inhibitory Effect of Pioglitazone on TGF-β1 Gene Expression in Renal Cortex of Diabetic Rats

Effects of Pioglitazone on MKP-1 and TSP-1 Expression in Early Stages of Diabetic Retinopathy Induced by Streptozotocin

Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice

Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats

Effect of different dosages of piogitazone on the level of oxidative stress in STZ-induced diabetic rats

Decreased Thrombospondin-I (TSP-I) Expression in the Hippocampus of Streptozotocin-Induced Diabetic Rats.

Intracerebroventricular Injection of Streptozotocin Caused Brain Energy Deficiency and Spatial Memory Impairment in Rats

Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity

Rosiglitazone Improves Cognitive Impairment in Streptozotocin-induced Diabetic Mice and its Mechanisms

Effect of Different Dosages of Piogtitazone on the Oxidative Stress in the Kidney of STZ-induced Diabetic Rats